In analysis of the up-regulated DEGs, the major differences between low-grade glioma and GBM are “nucleic acid binding proteins” and “transcription factors”, while depleting MBD3 further disturbs the expression of some “receptor proteins” (e.g., G-protein coupled receptors) in GBM cells (Figure S4). The gene discussed is MBD3; the disease is central nervous system cancer.